These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22923341)

  • 1. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients.
    Cheng A; Landman SR; Stadler RW
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):884-8. PubMed ID: 22923341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term retention of cardiac resynchronization therapy.
    Knight BP; Desai A; Coman J; Faddis M; Yong P
    J Am Coll Cardiol; 2004 Jul; 44(1):72-7. PubMed ID: 15234410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic ventricular overdrive stimulation in atrial fibrillation: effects on ventricular rate irregularity, ventricular pacing, and fusion beats.
    Nölker G; Gutleben KJ; Asbach S; Ritscher G; Marschang H; Sinha AM; Boileau P; Benser ME; Hallier B; Hümmer A; Brachmann J
    Europace; 2011 Dec; 13(12):1688-94. PubMed ID: 21784744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of RV pacing by continuous optimization of the AV interval.
    Milasinovic G; Sperzel J; Smith TW; Mead H; Brandt J; Haisty WK; Bailey JR; Roelke M; Simonson J; Gerritse B; Englund J; Compton SJ;
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):406-12. PubMed ID: 16650270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.
    Birnie D; Hudnall H; Lemke B; Aonuma K; Lee KL; Gasparini M; Gorcsan J; Cerkvenik J; Martin DO
    Heart Rhythm; 2017 Dec; 14(12):1820-1825. PubMed ID: 28893549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.
    Plummer CJ; Frank CM; Bári Z; Al Hebaishi YS; Klepfer RN; Stadler RW; Ghosh S; Liu S; Mittal S
    Heart Rhythm; 2018 Mar; 15(3):369-375. PubMed ID: 29132930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal sensed atrio-ventricular interval determined by paced QRS morphology.
    Van Gelder BM; Bracke FA; Van Der Voort PH; Meijer A
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):476-81. PubMed ID: 17437570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial pacing and sensing characteristics in heart failure patients undergoing cardiac resynchronization therapy.
    Schuchert A; Aydin MA; Israel C; Gaby G; Paul V
    Europace; 2005 Mar; 7(2):165-9. PubMed ID: 15763532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
    Gasparini M; Galimberti P; Ceriotti C
    Curr Opin Cardiol; 2013 Jan; 28(1):50-4. PubMed ID: 23196776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: a prospective hemodynamic study.
    Garrigue S; Bordachar P; Reuter S; Jaïs P; Haïssaguerre M; Clementy J
    Card Electrophysiol Rev; 2003 Dec; 7(4):315-24. PubMed ID: 15071245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial.
    Krum H; Lemke B; Birnie D; Lee KL; Aonuma K; Starling RC; Gasparini M; Gorcsan J; Rogers T; Sambelashvili A; Kalmes A; Martin D
    Am Heart J; 2012 May; 163(5):747-752.e1. PubMed ID: 22607850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.